ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 583,46
-0,65%
Dow Jones
40 717,09
1,26%
DAX
18 524,98
-0,40%
Brent Oil
83,485
-1,01%
Bitcoin
64 601,11
-0,39%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Italie
  5. BIT
  6. Abitare In Spa (ABT)

  7. Abitare In Spa (ABT) Actualités

ABT

Abitare In (ABT)

Abitare In Spa
De:
Trier par:
 Showing the most relevant articles for your search:BIT:ABT
DateHeureSourceTitreSymboleSociété
24/09/200901h09Dow Jones News2nd UPDATE:Abbott Stent Tops Boston Sci Devices In 2 StudiesNYSE:ABTAbbott Laboratories
24/09/200900h23Dow Jones NewsStudy Shows 2-Year Benefits For Stent-Guiding SystemNYSE:ABTAbbott Laboratories
23/09/200923h19Dow Jones NewsUPDATE: Abbott Stent Tops Boston Sci Devices In 2 StudiesNYSE:ABTAbbott Laboratories
23/09/200921h35Dow Jones NewsWSJ: Abbott Bids For Solvay Drug Unit - SourcesNYSE:ABTAbbott Laboratories
23/09/200921h13Dow Jones NewsAbbott Heart Stent Tops Newer Boston Sci Device In StudyNYSE:ABTAbbott Laboratories
23/09/200920h40Dow Jones NewsAbbott Stent Tops Older Boston Scientific Device In Big StudyNYSE:ABTAbbott Laboratories
21/09/200921h37Dow Jones News2nd UPDATE: Abbott, Medtronic: Stents Perform Well At 3 YearsNYSE:ABTAbbott Laboratories
21/09/200919h25Dow Jones NewsUPDATE: Abbott, Medtronic Say Stents Perform Well At 3 YearsNYSE:ABTAbbott Laboratories
21/09/200917h31Dow Jones NewsAbbott, Medtronic: Heart Stents Top Rival In 3-Year Study DataNYSE:ABTAbbott Laboratories
21/09/200917h00PR Newswire (US)Abbott's XIENCE V(R) Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long-Term Safety Results inNYSE:ABT
21/09/200915h03PR Newswire (US)Abbott Receives FDA Approval for First Fully Automated Blood Screening Test for HIV-1/HIV-2NYSE:ABT
17/09/200923h28Dow Jones NewsUPDATE: FDA Seeks Tighter Accuracy For Diabetes DevicesNYSE:ABTAbbott Laboratories
17/09/200922h30Dow Jones NewsFDA Seeking Tighter Accuracy Standards For Diabetes DevicesNYSE:ABTAbbott Laboratories
16/09/200915h30PR Newswire (US)Abbott Expands Use of Sustainable Packaging as Part of Global Environmental EffortsNYSE:ABT
15/09/200915h44PR Newswire (US)Abbott Wins Top Honor in Wall Street Journal Technology Innovation AwardsNYSE:ABT
14/09/200914h14Dow Jones NewsAbbott Gets Chinese Clearance For Xience V StentNYSE:ABTAbbott Laboratories
14/09/200913h00PR Newswire (US)Abbott Announces Approval in China for Next-Generation XIENCE V(R) Drug Eluting StentNYSE:ABT
11/09/200901h03Dow Jones NewsUPDATE: Abbott To Buy Heart-Valve Repair Co For Up To $410 MillionNYSE:ABTAbbott Laboratories
10/09/200923h11Dow Jones NewsAbbott To Buy Cardiac Valve Repair Tech Co. For Up To $410 MillionNYSE:ABTAbbott Laboratories
08/09/200923h19Dow Jones NewsUPDATE: Senate Health Proposal Includes Med-Device SavingsNYSE:ABTAbbott Laboratories
08/09/200922h10Dow Jones NewsUS Senate Health Proposal Seeks $4 Billion A Year From Medical Device CosNYSE:ABTAbbott Laboratories
02/09/200922h51Dow Jones NewsAbbott To Pay $400 Million For Cataract-Treatment Firm VisiogenNYSE:ABTAbbott Laboratories
01/09/200913h56Dow Jones News2nd UPDATE: SkyePharma Sees No Flutiform Approval Before 2011NYSE:ABTAbbott Laboratories
01/09/200910h25Dow Jones NewsUPDATE: SkyePharma Sees No Flutiform Approval Before 2nd Half, 2011NYSE:ABTAbbott Laboratories
01/09/200909h36Dow Jones NewsSkyePharma Sees No Flutiform Approval Before 2nd Half, 2011NYSE:ABTAbbott Laboratories
27/08/200915h00PR Newswire (US)Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-SmNYSE:ABT
26/08/200916h39Dow Jones NewsDoctor Files Patent-Infringement Suit Vs Abbott Over StentsNYSE:ABTAbbott Laboratories
25/08/200918h46Dow Jones NewsUPDATE: Medtronic 1Q Net Down 38% On Charges; Outlook SteadyNYSE:ABTAbbott Laboratories
25/08/200917h10Dow Jones NewsCORRECT: Medtronic 1Q Net Off 38% On Stent Suits; Top ViewsNYSE:ABTAbbott Laboratories
25/08/200914h24Dow Jones NewsMedtronic 1Q Net Off 39% On Stent Suits; Results Top ViewsNYSE:ABTAbbott Laboratories
 Showing the most relevant articles for your search:BIT:ABT

Dernières Valeurs Consultées

NYSE
PBA
Pembina Pipeline
COIN
EXCOBTC
ExcaliburCoin
BIT
P1Y201
NLBNPIT1Y201 20240920 3.2
LSE
CEPS
Ceps
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés